Oxonica Share Discussion Threads

[dieseltaylor] 17/5/2007 16:56

You will no doubt be as shocked as I was to read that nanotechnology can be beneficial when used with fuel ! Perhaps a small crumb of comfort that might enlarge to cake size if it is made mandatory. Time scale though would not be in weeks given Defra involvement.

[dieseltaylor] 13/5/2007 10:33

Technically not an additive and the Wikipedia article is very thorough.

[don muang] 09/5/2007 18:13

Similar to OXN product?

The trucks run on diesel, but an additive called Adblue claims to cut the pollution they create by breaking down some of the exhaust fumes into harmless nitrogen and water.

[cootuk] 07/5/2007 03:41

Anyone here also in Nanoscience (NAN)?
Currently lossmaking and looks like a fundraising on the horizon, but several of their products seem to be on the edge of commercialisation.
Not currently holding, but could be worth a look if you like nanotech.


From last years interim results:
"In March we provided further support to Future Waves Pte. Ltd by way of increased investment and subsequently the company achieved early successes in winning `design-ins' for its Fenix 1 chip in the Far East, with a positive reception from manufacturers of MP3, GPS and multimedia systems. Following the progress made in the first half of the year by Future Waves Pte. Ltd we are confident that volume orders will be receivedwithin the next six months.

Meanwhile our wholly owned subsidiary and Imperial College spin-off company,
Toumaz - which we acquired in October last year - continued to demonstrate
better than expected results in the ongoing testing of its ultra low-power
wireless Sensium chip. During the period, two key milestones were reached with
regards to the commercialisation of Toumaz's Sensium chip. Firstly, a number of
significant global players have taken delivery of proof of concept product from
the company and are presently trialing the ultra low-power wireless functionality of Sensium's continuous patient monitoring. Secondly, the single
chip Sensium is now entering the fabrication stage and following testing and
trials scheduled for the first quarter of next year, will be ready for
production engineering in advance of mass production by Toumaz's subcontract
manufacturing partner, Infineon Technologies AG. Throughout the period, Toumaz
received a number of significant customer enquiries into its products and of
particular encouragement has been the continued support from Oracle where both
they and Toumaz have progressed towards their mutual commercial goals.

AppliedSensor Sweden AB, the Group's first investment, has successfully
completed product testing within the automotive industry and orders have been
received from two leading manufacturers for integration in their upcoming 2007
production models. A first production order has also been received from a
leading supplier in the indoor air quality control sector."

[cootuk] 03/5/2007 20:22

If cash is very tight, then I guess a placing at a low price might be achievable.

[waldron] 03/5/2007 15:22

Oxonica Trading Statement


RNS Number:0683W
Oxonica plc
03 May 2007


3 May 2007


Oxonica plc


Trading Update


Further to the Company's request to suspend trading in its shares on Friday 30
April, the Company has taken immediate steps to reduce its operating expenses.


Thirteen of the 61 employees of the Company have been advised that their roles
are at risk of redundancy and appropriate consultation will follow.


At this date, the Company's net cash position is #3.6 million. The Company's
average monthly operating costs for the first quarter of 2007 was #900k
(exclusive of revenues), and therefore excludes any impact of possible
redundancies or revisions to its business plan.


A further announcement will be made when the Group's business plans have been
re-set, the Company is able to provide details on the termination arrangements
with Petrol Ofisi and the impact of the cost reduction exercise is known,
leading to clarification of the Company's financial position.


For further information, please contact:


Oxonica plc 01865 856 700

Kevin Matthews, Chief Executive

Richard Clarke, Finance Director


The Broadcast PR Business 020 7812 6021

Matthew Locke


Panmure Gordon 020 7459 3600

Hugh Morgan

Andrew Potts



Notes to Editors

About Oxonica plc - www.oxonica.com

Oxonica (AIM: OXN.L) is one of the leading International nanomaterials groups
with products already launched into international markets and is listed in
London on the AIM market. It was spun-out from Oxford University in 1999.
Oxonica's mission is to focus on the development of innovative commercial
solutions for international markets using its expertise in the design and
application of nanomaterials. It owns a portfolio of demand driven products that
offer substantial benefits to the target markets of energy, healthcare,
materials and security.

The Group currently has four operating divisions: Oxonica Energy, Oxonica
Healthcare, Oxonica Materials and Oxonica Security. Oxonica has already
launched products into international markets. Lead products include:

* EnviroxTM Fuel Borne Catalyst - a nanocatalyst improving fuel economy
and reducing emissions
* OptisolTM UV Absorber - a revolutionary photostable UV protection system
designed to optimise the performance of quality sunscreens and
anti-premature aging products


Oxonica is also active in searching for the next generation of products and is
already engaged in developing transformational detection technologies which will
enable a new generation of ultrasensitive multiplex diagnostic tools for the
clinical diagnostic life science and security markets. In addition, the company
is developing other UV absorber technologies into polymer systems and coatings,
based on similar technologies to that used in OptisolTM.



This information is provided by RNS
The company news service from the London Stock Exchange

END
TSTUUUACAUPMGCW

[waldron] 03/5/2007 15:21

Oxonica says mulling redundancies as part of cost-cutting exercise


LONDON (Thomson Financial) - Oxonica PLC said it has taken immediate steps
to reduce operating expenses pending talks with Petrol Ofisi on the planned
termination of a supply deal and that it has therefore warned 13 of its 61
employees that their roles are at risk of redundancy.
The nanomaterials group, whose shares were suspended from trading on April
30, said it will make a further announcement once it has clarified its financial
position based on the arrangements with Petrol Ofisi and the impact of the
cost-cutting measures.
Oxonica added that it has net cash of 3.6 mln stg at this date and that
average monthly operating costs for the first quarter were 900,000 stg.

[e-mail]
vlb

[dieseltaylor] 02/5/2007 07:32

Apparently 60% of the Oxford staff were sacked yesterday according to the iii forum. Remarks on the management are not flattering. It may be a bigger write down than I expected however we do have Optisol and the Envirox in Europe so there is some value to be had.

At least the staff sacking is a step for the companies survival even as we sympathise with the staff.

[cootuk] 01/5/2007 14:13

From Finals:
"In order to sell EnviroxTM into the United States for on-highway use, a US EPA
registration is required. Oxonica Energy made its submission regarding EnviroxTM to the EPA in April 2005. The EPA responded with a request for further data in October 2005 and this additional data was submitted to the EPA in May 2006. EPA have subsequently confirmed that EnviroxTM satisfies Tier 1 requirements, however, the EPA have a further six months to consider whether further testing will be required prior to registering the product."


So Nov 06 at latest before they know if they need more testing for the US.
Envirox also sells in the UK, italy, and Germany.

[dieseltaylor] 30/4/2007 07:41

Damanko
The EPA have not approved it but I believe the testing has been completed and the latest the announcement can be is June or July. Sorry I am dredging these thoughts from my memory but perhaps someone can recall or provide more facts.

I feel fairly useless this morning but lots to do and no time available : (

[damanko] 29/4/2007 22:23

It's been used for more than a couple of years with Stagecoach, that much is public knowledge. It is being tested in the States, again, public knowledge. Erm ..... buying opportunity?

[cootuk] 27/4/2007 18:17

From the Finals
"The agreement with Petrol Ofisi, signed in July 2006, resulted in £7.6 million of additional revenues being booked in the year" on turnover of £9.1m

That would mean turnover could drop to £1.5m for this year, plus costs in writing off the Turkish offices and carrying stock that they were going to supply to Petrol Ofisi....so almost back to 2005 results which were a loss of around £4.5m?

With £6.8m cash they really need to get Envirox into the US market at all costs.

[cootuk] 27/4/2007 15:13

So it looks like the additive in high sulphur diesel is unsuitable for Petrol Ofisi - so now it will be about how much material they want to call off for low sulphur diesel or whether they are calling the whole thing off?

[waldron] 27/4/2007 14:30

Suspension - Oxonica


RNS Number:6683V
AIM
27 April 2007

NOTICE

(241)

27/04/2007 14:15

TEMPORARY SUSPENSION OF TRADING ON AIM

OXONICA PLC

At the request of the company trading on AIM for the under-mentioned securities
has been temporarily suspended from 27/04/2007 14:15 pending clarification of
the company's financial position.

Ordinary Shares of 1p each (B0D09P4)(GB00B0D09P49)
fully paid

If you have any queries relating to the above, please contact the company's
nominated adviser on 020 7459 3600.

AIM Regulation

Ref: AIMNOT241


This information is provided by RNS
The company news service from the London Stock Exchange
END
EXCSEFFLWSWSESL

[mw] 20/4/2007 14:43

"key technology development in healthcare
is expected to be announced on April 19."

I'm still waiting

[dieseltaylor] 17/4/2007 13:12

19th April :)
Dr. Michael Natan will be discussing Oxonica's NANOPLEX™ biomarker detection platform for Point-of-Care Diagnostics at the 39th annual Oak Ridge conference: Harnessing New Technolocy for Clinical Diagnostics. Oak Ridge will take place at Hyatt Regency Hotel, St Louis, USA, 19th - 20th April 2007.
Trusting for good news.

[fredd] 10/4/2007 13:08

You can say that again!

[eire voyager] 10/4/2007 12:59

This share is far too volatile for my liking. The company should issue an RNS to clarify the situation.

[eire voyager] 10/4/2007 12:59

This share is far too volatile for my liking. The company should issue an RNS to clarify the situation.

[eire voyager] 10/4/2007 12:59

This share is far too volatile for my liking. The company should issue an RNS to clarify the situation.

[cootuk] 09/4/2007 21:58

Precisely...I guess Oxonica will adapt the mix as neccessary and file patents around the areas not covered by Neuftec patents. A lot will depends on how Neuftec patents have been written and how wide ranging they are.

[dieseltaylor] 09/4/2007 15:11

Oxonica has the exclusive license to 2021. Must be the way Oxonica are using it ...who knows !